Stock | Jotup

Forum Merger III Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing September 21, 2020

Finance, Financial markets, Money, Equity securities, Corporate finance, Stock market, Options, Warrant, NASDAQ, Stock

Friday, September 18, 2020 - 5:46pm

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points:

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
The shares of Class A common stock and warrants that are separated will trade on The Nasdaq Capital Market (Nasdaq) under the symbols FIII and FIIIW, respectively.
Those units not separated will continue to trade on Nasdaq under the symbol FIIIU.
Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into shares of Class A common stock and warrants.

Snowflake Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Software, Technology, Internet, Data management, Finance, Financial markets, Money, Primary dealers, Stock market, 73rd United States Congress, Canaccord Genuity, Mizuho Securities, Securities Act, Morgan Stanley, Genuity, Stock

Friday, September 18, 2020 - 5:02pm

Snowflake, the cloud data platform, today announced the closing of its initial public offering of 32,200,000 shares of Class A common stock, including the full exercise by the underwriters of their option to purchase 4,200,000 additional shares of Class A common stock, at a price to the public of $120.00 per share.

Key Points:

Snowflake, the cloud data platform, today announced the closing of its initial public offering of 32,200,000 shares of Class A common stock, including the full exercise by the underwriters of their option to purchase 4,200,000 additional shares of Class A common stock, at a price to the public of $120.00 per share.
The shares are listed for trading on the New York Stock Exchange under the ticker symbol SNOW.
Goldman Sachs & Co. LLC, Morgan Stanley, J.P. Morgan, Allen & Company LLC, and Citigroup acted as lead book-running managers for the offering.
Credit Suisse, Barclays, Deutsche Bank Securities, Mizuho Securities, and Truist Securities acted as book-running managers, and BTIG, Canaccord Genuity, Capital One Securities, Cowen, D.A.

StepStone Announces Closing of Initial Public Offering

Finance, Financial services, Banks, Primary dealers, Subprime mortgage crisis, UBS, Initial public offering, Investment banking, Stock, Goldman Sachs, Morgan Stanley, Barclays

Friday, September 18, 2020 - 4:54pm

NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced the closing of its initial public offering of 20,125,000 shares of its Class A common stock, which includes the exercise in full by the underwriters of their option to purchase up to 2,625,000 additional shares of Class A common stock, at a public offering price of $18.00 per share.

Key Points:

NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced the closing of its initial public offering of 20,125,000 shares of its Class A common stock, which includes the exercise in full by the underwriters of their option to purchase up to 2,625,000 additional shares of Class A common stock, at a public offering price of $18.00 per share.
The shares began trading on the Nasdaq Global Select Market on September 16, 2020 under the ticker symbol STEP.
J.P. Morgan, Goldman Sachs & Co. LLC and Morgan Stanley acted as joint lead book-running managers for the offering.
Barclays and UBS Investment Bank acted as joint book-running managers for the offering.

Shuman, Glenn & Stecker Investigates Nutanix, Inc.

Legal, Professional services, Financial markets, Cloud storage, Nutanix, Financial economics, Stecker, Shuman, Stock, Finance

Friday, September 18, 2020 - 2:30pm

Shuman, Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Nutanix, Inc. (Nutanix or the Company) (NASDAQ: NTNX ).

Key Points:

Shuman, Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Nutanix, Inc. (Nutanix or the Company) (NASDAQ: NTNX ).
In reality, Nutanix was experiencing unprecedented sales force attrition and flattened spending on lead generation, while redirecting Company funds to R&D.
On this news, the Companys stock price fell $16.39 per share, or more than 32%, to close at $33.70.
If you currently own Nutanix common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Brett Stecker toll free at (866) 569-4531 or email Mr. Stecker at brett@shumanlawfirm.com
Shuman, Glenn & Stecker represents investors throughout the nation, concentrating its practice in stockholder litigation.

Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Stock market, Financial economics, Corporate finance, Finance, Money, Initial public offering, Stock, Greenshoe

Friday, September 18, 2020 - 2:00pm

All shares of common stock to be sold in the public offering are being sold by Adamis.

Key Points:

All shares of common stock to be sold in the public offering are being sold by Adamis.
The offering is expected to close on September 22, 2020, subject to the satisfaction of customary closing conditions.
The company has also granted the underwriters a 30-day option to purchase up to 2,419,354 additional shares of its common stock to cover over-allotments, if any.
Raymond James& Associates, Inc. is acting as the sole book-running manager for the offering.

Cardlytics Announces Pricing of Offering of $200 Million of Convertible Senior Notes

Financial economics, Finance, Corporate finance, Stock market, Equity securities, Financial markets, Stock, Convertible security, Short, Convertible bond, Preferred stock

Friday, September 18, 2020 - 12:00pm

Cardlytics also granted the initial purchasers of the notes an option to purchase up to an additional $30 million principal amount of notes.

Key Points:

Cardlytics also granted the initial purchasers of the notes an option to purchase up to an additional $30 million principal amount of notes.
The notes will be convertible under certain circumstances into cash, shares of Cardlytics common stock or a combination of cash and shares of Cardlytics common stock, at Cardlytics election.
If Cardlytics elects to redeem less than all of the notes, at least $75.0 million aggregate principal amount of notes must be outstanding and not subject to redemption as of the relevant redemption notice date.
The capped call transactions cover, subject to customary adjustments, the number of shares of Cardlytics common stock that will initially underlie the notes.

Essential Properties Realty Trust, Inc. Announces Pricing of Upsized Primary Public Offering of Common Stock

REIT, Finance, Banking, Professional services, Construction & Property, Financial markets, Financial economics, Finance, Corporate finance, Stock market, Stock, Option, Greenshoe

Friday, September 18, 2020 - 2:59am

Essential Properties Realty Trust, Inc. (NYSE: EPRT; the Company) announced today the pricing of an underwritten public offering of 8,800,000 shares of its common stock at a public offering price of $19.00 per share.

Key Points:

Essential Properties Realty Trust, Inc. (NYSE: EPRT; the Company) announced today the pricing of an underwritten public offering of 8,800,000 shares of its common stock at a public offering price of $19.00 per share.
The Company has granted the underwriters a 30-day option to purchase up to an additional 1,320,000 shares of common stock.
The offering was upsized from the previously announced offering size of 8,000,000 shares of common stock.
All of the shares are being offered by the Company, and the offering is expected to close on September 22, 2020.

Athira Pharma Announces Pricing of Initial Public Offering

Finance, Financial markets, Financial economics, Corporate finance, Stock market, Athira Pharma, Initial public offering, Underwriting, Public offering, Stock, NASDAQ

Friday, September 18, 2020 - 1:21am

SEATTLE, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc., (Nasdaq: ATHA) (Athira), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the pricing of its initial public offering of 12,000,000 shares of its common stock at a price to the public of $17.00 per share.

Key Points:

SEATTLE, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc., (Nasdaq: ATHA) (Athira), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the pricing of its initial public offering of 12,000,000 shares of its common stock at a price to the public of $17.00 per share.
All of the shares of common stock are being offered by Athira.
The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Athira, are expected to be$204.0 million.
In addition, Athira has granted the underwriters a 30-day option to purchase up to an additional 1,800,000 shares of Athiras common stock at the initial public offering price less the underwriting discounts and commissions.

Unity Announces Pricing of Initial Public Offering

Friday, September 18, 2020 - 12:46am

Unity Software Inc. (Unity) today announced the pricing of its initial public offering of 25,000,000 shares of common stock at a price to the public of $52.00 per share.

Key Points:

Unity Software Inc. (Unity) today announced the pricing of its initial public offering of 25,000,000 shares of common stock at a price to the public of $52.00 per share.
In addition, Unity has granted the underwriters a 30-day option to purchase up to 3,750,000 additional shares of common stock at the initial public offering price less underwriting discounts and commissions.
Goldman Sachs & Co. LLC and Credit Suisse Securities (USA) LLC are acting as lead book-running managers for the proposed offering.
Oppenheimer & Co., Piper Sandler, Stifel, Wedbush Securities, Academy Securities and Siebert Williams Shank are acting as co-managers for the offering.

Kadant Declares Cash Dividend

Financial markets, Financial economics, Kadant, Corporate finance, Equity securities, Dividend, Forward-looking statement, Stock, Westford, Massachusetts

Thursday, September 17, 2020 - 9:32pm

WESTFORD, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.24 per share to be paid on November 12, 2020 to stockholders of record as of the close of business on October 15, 2020.

Key Points:

WESTFORD, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.24 per share to be paid on November 12, 2020 to stockholders of record as of the close of business on October 15, 2020.
Kadant Inc. is a global supplier of high-value, critical components and engineered systems used in process industries worldwide.
Kadant is based in Westford, Massachusetts, with approximately 2,700 employees in 20 countries worldwide.
The following constitutes a Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties, including forward-looking statements about our business, financial performance and cash dividend program.